Clearwater International acted as sole financial adviser to mic AG and its co-shareholders on the sale of 90.55% of the outstanding shares in neuroConn GmbH (“neuroConn”) to NeuroCare Group, owned by a consortium of investors led by Passion Investment Group (Australia).
neuroConn, founded 2005 in Ilmenau (Germany), is the leading specialist focused on the development of best-in-class medical instruments and complete systems for non-invasive treatments of severe neurological & psychiatric diseases and the world’s first supplier of complete, certified, multi-channel EEG feedback devices for neurofeedback of slow cortical potentials (SCP-Feedback).
neuroConn is active in the fast growing, multibillion USD market for neurostimulation. With its DC-STIMULATOR products, the company offers a highly innovative, validated and certified transcranial Direct Current Stimulation based non-invasive treatment method for e.g. depression, stroke, migraine or tinnitus etc.
As a venture capitalist, Munich-based mic AG invests at an early stage in promising companies in the clean-tech, life sciences, microsystems, optics and software/IT sectors.
Clearwater International, led by partner Tobias Schätzmüller, advised mic.